Documentation Centre

 

 

  of 73 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Effects of dietary sodium on metabolites: the Dietary Approaches to Stop Hypertension (DASH)-Sodium Feeding Study. Am J Clin Nutr. 2017;106:1131-1141 November 29, 2017 Effects of dietary sodium on metabolites: the Dietary Approaches to Stop Hypertension (DASH)-Sodium Feeding Study. Am J Clin Nutr. 2017;106:1131-1141 Derkach A, Sampson J, Joseph J, Playdon MC, Stolzenberg-Solomon RZ Key Publications
High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Atherosclerosis. 2017;263:104-111 November 22, 2017 High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Atherosclerosis. 2017;263:104-111 Liu HH, Guo YL, Wu NQ, Zhu CG, Gao Y, Qing P, Li S, Zhao X, Zhang Y, Sun D, Liu G, Dong Q, Li JJ Key Publications
High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Atherosclerosis. 2017;263:104-111 November 22, 2017 High-density lipoprotein cholesterol levels are associated with coronary severity but not with outcomes in new-onset patients with stable coronary artery disease. Atherosclerosis. 2017;263:104-111 Liu HH, Guo YL, Wu NQ, Zhu CG, Gao Y, Qing P, Li S, Zhao X, Zhang Y, Sun D, Liu G, Dong Q, Li JJ Key Publications
Diabetes and hypertension: A position statement by the American Diabetes Association. Diabetes Care. 2017;40:1273-1284 November 15, 2017 Diabetes and hypertension: A position statement by the American Diabetes Association. Diabetes Care. 2017;40:1273-1284 de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G Key Publications
Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes. J Am Coll Cardiol. 2017;70:704-712 November 03, 2017 Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes. J Am Coll Cardiol. 2017;70:704-712 Januzzi JL Jr, Butler J, Jarolim P, Sattar N, Vijapurkar U, Desai M, Davies MJ Key Publications
Leaving the glucocentric view: Can SGLT2 inhibitors halt CVD in patients with type 2 diabetes? J Am Coll Cardiol. 2017;70:713-714 November 03, 2017 Leaving the glucocentric view: Can SGLT2 inhibitors halt CVD in patients with type 2 diabetes? J Am Coll Cardiol. 2017;70:713-714 Marx N Key Publications
What additional pragmatic large nutritional trial would you like to conduct? What would be your priority question? October 11, 2017 What additional pragmatic large nutritional trial would you like to conduct? What would be your priority question? Frank M. Sacks, MD, FAHA, Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, United States Expert Opinions
Video 1:24 min.
(7 MB)
Mitigating cardiovascular risk in type 2 diabetes with antidiabetes drugs: A review of principal cardiovascular outcome results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 trials. Diabetes Care. 2017;40:821-831 October 09, 2017 Mitigating cardiovascular risk in type 2 diabetes with antidiabetes drugs: A review of principal cardiovascular outcome results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 trials. Diabetes Care. 2017;40:821-831 Kaul S Key Publications
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389:2226-2237 September 29, 2017 Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017;389:2226-2237 Böhm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Weber MA, Williams B, Yusuf S Key Publications
Target blood pressure in patients at high cardiovascular risk. Lancet. 2017;389:2170-2172 September 29, 2017 Target blood pressure in patients at high cardiovascular risk. Lancet. 2017;389:2170-2172 Kahan T. Key Publications

  of 73 Next page

Go to page: of